[{"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "6500.00", "Date_of_Payment": "12/12/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "263311378", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "3150.00", "Date_of_Payment": "07/29/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "294741638", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "3150.00", "Date_of_Payment": "04/28/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304908", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "3150.00", "Date_of_Payment": "08/12/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304938", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Onyx Pharmaceuticals, Inc., an Amgen subsidiary", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000276", "Total_Amount_of_Payment_USDollars": "3000.00", "Date_of_Payment": "11/11/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "227549530", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "3000.00", "Date_of_Payment": "09/15/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "297314904", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "3000.00", "Date_of_Payment": "09/01/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "297314912", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "3000.00", "Date_of_Payment": "11/05/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "297314936", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "3000.00", "Date_of_Payment": "04/21/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "297915462", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "2700.00", "Date_of_Payment": "05/20/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "294839232", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "2700.00", "Date_of_Payment": "05/13/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "294789684", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "2700.00", "Date_of_Payment": "10/14/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304956", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "2700.00", "Date_of_Payment": "03/19/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304874", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "2700.00", "Date_of_Payment": "04/09/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304881", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "2500.00", "Date_of_Payment": "11/13/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104545054", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT ARCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "2500.00", "Date_of_Payment": "11/04/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104544818", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT ARCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "2500.00", "Date_of_Payment": "02/28/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "198459984", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "2500.00", "Date_of_Payment": "02/21/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "198460026", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "2500.00", "Date_of_Payment": "05/22/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "198459936", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "2450.00", "Date_of_Payment": "12/19/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "168613966", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "2450.00", "Date_of_Payment": "08/19/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332520553", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "YERVOY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "2100.00", "Date_of_Payment": "02/12/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "168511288", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "2100.00", "Date_of_Payment": "07/17/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221254504", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "2100.00", "Date_of_Payment": "02/27/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221253996", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "2100.00", "Date_of_Payment": "01/21/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "295258340", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "2100.00", "Date_of_Payment": "07/09/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "318241064", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Perjeta", "Name_of_Associated_Covered_Drug_or_Biological2": "Kadcyla", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "2000.00", "Date_of_Payment": "09/25/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "21809143", "Nature_of_Payment_or_Transfer_of_Value": "Honoraria", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "2000.00", "Date_of_Payment": "11/21/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "21809138", "Nature_of_Payment_or_Transfer_of_Value": "Honoraria", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "2000.00", "Date_of_Payment": "09/24/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152649510", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "2000.00", "Date_of_Payment": "09/25/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152649500", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "2000.00", "Date_of_Payment": "05/21/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152649528", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "2000.00", "Date_of_Payment": "05/21/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152649520", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "2000.00", "Date_of_Payment": "03/13/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "173389148", "Nature_of_Payment_or_Transfer_of_Value": "Honoraria", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "2000.00", "Date_of_Payment": "03/10/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "263311398", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Onyx Pharmaceuticals, Inc., an Amgen subsidiary", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000276", "Total_Amount_of_Payment_USDollars": "1750.00", "Date_of_Payment": "11/04/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "227549534", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "1721.13", "Date_of_Payment": "03/10/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "263311396", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "SANDOSTATIN LAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "1600.00", "Date_of_Payment": "11/07/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "111780490", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "1600.00", "Date_of_Payment": "09/26/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "111800120", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "1500.00", "Date_of_Payment": "05/06/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "189920168", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "1500.00", "Date_of_Payment": "07/22/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "189919324", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Onyx Pharmaceuticals, Inc., an Amgen subsidiary", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000276", "Total_Amount_of_Payment_USDollars": "1500.00", "Date_of_Payment": "05/06/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "227549526", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Onyx Pharmaceuticals, Inc., an Amgen subsidiary", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000276", "Total_Amount_of_Payment_USDollars": "1500.00", "Date_of_Payment": "01/15/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "227549522", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "1500.00", "Date_of_Payment": "09/19/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "263311388", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "1500.00", "Date_of_Payment": "05/19/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "328261916", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "1500.00", "Date_of_Payment": "11/24/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "328502454", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "1437.66", "Date_of_Payment": "11/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168648724", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "1250.00", "Date_of_Payment": "09/11/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "328260564", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "1225.00", "Date_of_Payment": "10/04/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "168531790", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "1225.00", "Date_of_Payment": "10/04/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "168650377", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "1066.20", "Date_of_Payment": "07/16/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304924", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "1020.60", "Date_of_Payment": "09/17/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104544808", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT ARCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "1019.00", "Date_of_Payment": "04/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198459974", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "810.24", "Date_of_Payment": "05/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328499478", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "804.20", "Date_of_Payment": "06/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295272550", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "800.00", "Date_of_Payment": "09/18/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "8941497", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XGEVA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "800.00", "Date_of_Payment": "08/28/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "198459924", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "772.20", "Date_of_Payment": "10/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168484108", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "769.80", "Date_of_Payment": "10/01/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104545050", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT ARCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "747.20", "Date_of_Payment": "08/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297314916", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "700.00", "Date_of_Payment": "12/19/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "168861156", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "664.60", "Date_of_Payment": "07/16/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304926", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "631.20", "Date_of_Payment": "06/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "294704016", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "615.42", "Date_of_Payment": "03/18/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "198460022", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "600.00", "Date_of_Payment": "12/16/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104547498", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT ARCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "ARIAD Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010550", "Total_Amount_of_Payment_USDollars": "600.00", "Date_of_Payment": "11/14/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "325872518", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Iclusig", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "556.46", "Date_of_Payment": "05/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "294752466", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "543.20", "Date_of_Payment": "04/16/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304896", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "528.40", "Date_of_Payment": "09/24/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152649508", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "516.00", "Date_of_Payment": "11/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168381190", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "511.08", "Date_of_Payment": "05/26/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198459954", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "500.00", "Date_of_Payment": "06/24/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "263311372", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "496.80", "Date_of_Payment": "10/14/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304958", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "481.20", "Date_of_Payment": "07/17/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332513795", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "YERVOY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "449.74", "Date_of_Payment": "10/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168927252", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "440.20", "Date_of_Payment": "08/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328266872", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "436.37", "Date_of_Payment": "05/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328263992", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "432.20", "Date_of_Payment": "10/09/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104545052", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT ARCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "432.20", "Date_of_Payment": "05/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328499476", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "423.00", "Date_of_Payment": "12/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311392", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "406.75", "Date_of_Payment": "11/20/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "297314932", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "390.00", "Date_of_Payment": "11/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "21809142", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "384.80", "Date_of_Payment": "10/01/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104545046", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT ARCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "372.60", "Date_of_Payment": "11/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328286064", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "350.00", "Date_of_Payment": "11/12/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "111807036", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "337.87", "Date_of_Payment": "11/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328285824", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "325.92", "Date_of_Payment": "05/21/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152649518", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "321.33", "Date_of_Payment": "11/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168837114", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "312.88", "Date_of_Payment": "05/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198459948", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "307.59", "Date_of_Payment": "11/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "21809140", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "301.28", "Date_of_Payment": "09/26/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111735586", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "300.75", "Date_of_Payment": "09/24/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104544810", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT ARCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "288.09", "Date_of_Payment": "01/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168764124", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "280.00", "Date_of_Payment": "04/16/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304898", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "272.93", "Date_of_Payment": "08/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328266796", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "272.23", "Date_of_Payment": "11/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328285690", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "267.68", "Date_of_Payment": "07/16/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304930", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "265.90", "Date_of_Payment": "11/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328286040", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Incyte Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000263", "Total_Amount_of_Payment_USDollars": "250.00", "Date_of_Payment": "11/14/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "298503362", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "239.12", "Date_of_Payment": "03/07/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "198459978", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "236.17", "Date_of_Payment": "07/17/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332513761", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "YERVOY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "234.18", "Date_of_Payment": "12/12/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "263311376", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "229.13", "Date_of_Payment": "06/09/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "328263988", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "223.10", "Date_of_Payment": "05/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "294712716", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "220.19", "Date_of_Payment": "04/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "294717846", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "215.83", "Date_of_Payment": "11/07/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111803680", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "213.90", "Date_of_Payment": "04/21/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "297915460", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "213.57", "Date_of_Payment": "12/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311374", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "210.46", "Date_of_Payment": "09/19/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "263311386", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "201.41", "Date_of_Payment": "08/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297314920", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "200.48", "Date_of_Payment": "11/07/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111756650", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "198.88", "Date_of_Payment": "09/26/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111737592", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "196.85", "Date_of_Payment": "03/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198460009", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "195.38", "Date_of_Payment": "02/27/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221254002", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "189.61", "Date_of_Payment": "08/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328263824", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "189.28", "Date_of_Payment": "04/16/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304902", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "183.12", "Date_of_Payment": "02/27/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221255176", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "179.68", "Date_of_Payment": "09/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311384", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "174.08", "Date_of_Payment": "07/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317992022", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Perjeta", "Name_of_Associated_Covered_Drug_or_Biological2": "Kadcyla", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "172.26", "Date_of_Payment": "03/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198459989", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "170.23", "Date_of_Payment": "09/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649498", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "170.23", "Date_of_Payment": "09/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649506", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "168.29", "Date_of_Payment": "08/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328258534", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "166.88", "Date_of_Payment": "07/17/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221255258", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "166.88", "Date_of_Payment": "03/18/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304868", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "166.25", "Date_of_Payment": "05/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328264546", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "153.23", "Date_of_Payment": "07/17/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221254508", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "152.32", "Date_of_Payment": "09/26/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104544812", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT ARCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "146.42", "Date_of_Payment": "11/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "21809141", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "145.61", "Date_of_Payment": "08/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297314928", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "144.08", "Date_of_Payment": "08/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297314926", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "143.08", "Date_of_Payment": "06/05/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "198459932", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "139.70", "Date_of_Payment": "07/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189916428", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "139.19", "Date_of_Payment": "04/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297915458", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "136.52", "Date_of_Payment": "09/26/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104544814", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT ARCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "135.21", "Date_of_Payment": "09/28/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304948", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Seattle Genetics, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "WA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000279", "Total_Amount_of_Payment_USDollars": "135.16", "Date_of_Payment": "08/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "341825358", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ADCETRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "134.84", "Date_of_Payment": "05/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649516", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "126.52", "Date_of_Payment": "12/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328494230", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "125.00", "Date_of_Payment": "10/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168707323", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "125.00", "Date_of_Payment": "10/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297314908", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "ARIAD Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010550", "Total_Amount_of_Payment_USDollars": "124.55", "Date_of_Payment": "11/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "325872582", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Iclusig", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "119.42", "Date_of_Payment": "09/19/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "263311390", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "117.70", "Date_of_Payment": "09/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "138087970", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Millennium Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000080", "Total_Amount_of_Payment_USDollars": "115.09", "Date_of_Payment": "05/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "335417042", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VELCADE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Onyx Pharmaceuticals, Inc., an Amgen subsidiary", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000276", "Total_Amount_of_Payment_USDollars": "113.68", "Date_of_Payment": "10/03/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "102468644", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "113.00", "Date_of_Payment": "05/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267746910", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "FOOD & BEVERAGE EXPENSES FOR A MEETING WHICH MAY HAVE INCLUDED MULTIPLE DAYS AND MAY HAVE HAD MULTIPLE MEALS PER DAY"}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "ASD Specialty Healthcare, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "TX", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010920", "Total_Amount_of_Payment_USDollars": "112.84", "Date_of_Payment": "10/30/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "195521440", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "109.79", "Date_of_Payment": "04/09/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304884", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "105.85", "Date_of_Payment": "11/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290464968", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Onyx Pharmaceuticals, Inc., an Amgen subsidiary", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000276", "Total_Amount_of_Payment_USDollars": "103.59", "Date_of_Payment": "12/04/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "102468250", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "102.99", "Date_of_Payment": "04/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339304904", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "100.38", "Date_of_Payment": "11/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318132468", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Perjeta", "Name_of_Associated_Covered_Drug_or_Biological2": "Kadcyla", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "98.58", "Date_of_Payment": "07/17/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221254506", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Onyx Pharmaceuticals, Inc., an Amgen subsidiary", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000276", "Total_Amount_of_Payment_USDollars": "97.99", "Date_of_Payment": "10/29/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "227549528", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Onyx Pharmaceuticals, Inc., an Amgen subsidiary", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000276", "Total_Amount_of_Payment_USDollars": "97.62", "Date_of_Payment": "04/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "227549524", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "97.46", "Date_of_Payment": "04/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328257518", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Alexion Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005462", "Total_Amount_of_Payment_USDollars": "97.28", "Date_of_Payment": "11/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "338123776", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLIRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "97.12", "Date_of_Payment": "04/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297915456", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "96.29", "Date_of_Payment": "11/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168916216", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "96.06", "Date_of_Payment": "06/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290464970", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "95.44", "Date_of_Payment": "10/09/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "101789754", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "95.22", "Date_of_Payment": "09/26/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111763796", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "94.85", "Date_of_Payment": "04/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297915450", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "94.27", "Date_of_Payment": "08/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189888904", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "94.11", "Date_of_Payment": "08/27/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "14240859", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELITEK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "93.48", "Date_of_Payment": "07/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "294815062", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "91.81", "Date_of_Payment": "03/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196311024", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "GILOTRIF", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "91.44", "Date_of_Payment": "09/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649512", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "91.28", "Date_of_Payment": "11/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168537124", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "90.48", "Date_of_Payment": "03/13/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "173389142", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Seattle Genetics, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "WA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000279", "Total_Amount_of_Payment_USDollars": "89.16", "Date_of_Payment": "08/20/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "25422790", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SGN35", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "88.62", "Date_of_Payment": "02/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "274993734", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "88.61", "Date_of_Payment": "09/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "319050146", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JEVTANA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "88.45", "Date_of_Payment": "09/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "319179767", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JEVTANA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "88.36", "Date_of_Payment": "06/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328258026", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "87.86", "Date_of_Payment": "09/25/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "21809144", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Cardinal Health 108, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "OH", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010445", "Total_Amount_of_Payment_USDollars": "87.47", "Date_of_Payment": "09/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "145691442", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "86.94", "Date_of_Payment": "06/24/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "274993742", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pharmacyclics LLC, An AbbVie Company", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000136439", "Total_Amount_of_Payment_USDollars": "86.64", "Date_of_Payment": "10/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "326067400", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "IMBRUVICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Cardinal Health 108, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "OH", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010445", "Total_Amount_of_Payment_USDollars": "86.60", "Date_of_Payment": "04/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "145688324", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "86.28", "Date_of_Payment": "03/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198459995", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Cardinal Health 108, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "OH", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010445", "Total_Amount_of_Payment_USDollars": "86.20", "Date_of_Payment": "09/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "145691474", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "86.03", "Date_of_Payment": "05/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297915464", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "85.88", "Date_of_Payment": "12/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311380", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "84.85", "Date_of_Payment": "12/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189940456", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "84.81", "Date_of_Payment": "12/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311432", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "83.47", "Date_of_Payment": "04/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168442458", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "83.00", "Date_of_Payment": "03/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311400", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "SANDOSTATIN LAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "82.89", "Date_of_Payment": "06/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328277426", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "82.88", "Date_of_Payment": "05/21/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152649526", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "82.00", "Date_of_Payment": "10/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297314946", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Onyx Pharmaceuticals, Inc., an Amgen subsidiary", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000276", "Total_Amount_of_Payment_USDollars": "80.89", "Date_of_Payment": "11/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "227549532", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "76.61", "Date_of_Payment": "09/20/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104551934", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "BENLYSTA", "Name_of_Associated_Covered_Drug_or_Biological2": "BEXXAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Cardinal Health 108, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "OH", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010445", "Total_Amount_of_Payment_USDollars": "75.34", "Date_of_Payment": "06/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "145688384", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "74.55", "Date_of_Payment": "09/24/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152649514", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "74.55", "Date_of_Payment": "09/25/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152649504", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "73.00", "Date_of_Payment": "05/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "274993736", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Medical Textbook"}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "71.68", "Date_of_Payment": "07/17/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332513597", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "YERVOY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "71.64", "Date_of_Payment": "05/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649522", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Cardinal Health 108, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "OH", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010445", "Total_Amount_of_Payment_USDollars": "71.07", "Date_of_Payment": "08/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "292915660", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "69.89", "Date_of_Payment": "11/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "331048997", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "KEYTRUDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Cardinal Health 108, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "OH", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010445", "Total_Amount_of_Payment_USDollars": "65.61", "Date_of_Payment": "01/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "292915208", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Onyx Pharmaceuticals, Inc., an Amgen subsidiary", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000276", "Total_Amount_of_Payment_USDollars": "65.31", "Date_of_Payment": "12/19/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "102469264", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Cardinal Health 108, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "OH", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010445", "Total_Amount_of_Payment_USDollars": "65.21", "Date_of_Payment": "10/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "145691628", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Cardinal Health 108, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "OH", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010445", "Total_Amount_of_Payment_USDollars": "64.75", "Date_of_Payment": "11/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "145691784", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "60.00", "Date_of_Payment": "10/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168643897", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "59.00", "Date_of_Payment": "05/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649524", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "56.54", "Date_of_Payment": "11/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "21809139", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "56.00", "Date_of_Payment": "02/27/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221253998", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Cardinal Health 108, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "OH", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010445", "Total_Amount_of_Payment_USDollars": "54.75", "Date_of_Payment": "09/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "292915728", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "54.39", "Date_of_Payment": "04/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295213042", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "53.75", "Date_of_Payment": "07/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189918882", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Gilead Sciences Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000108", "Total_Amount_of_Payment_USDollars": "52.14", "Date_of_Payment": "12/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168306492", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "755692-1866979-8034211 - 1651767 - 20498661-1651767-Gilead Sciences-VRL"}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "52.00", "Date_of_Payment": "04/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339304886", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Products, LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000325", "Total_Amount_of_Payment_USDollars": "51.99", "Date_of_Payment": "08/19/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "17399988", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Zytiga", "Name_of_Associated_Covered_Drug_or_Biological2": "Doxil", "Contextual_Information": "Medical Textbook"}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "51.99", "Date_of_Payment": "09/24/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111799048", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "ASD Specialty Healthcare, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "TX", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010920", "Total_Amount_of_Payment_USDollars": "51.30", "Date_of_Payment": "08/26/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "103132492", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "51.00", "Date_of_Payment": "07/18/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332513697", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "YERVOY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "50.96", "Date_of_Payment": "11/06/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24099925", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Cardinal Health 108, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "OH", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010445", "Total_Amount_of_Payment_USDollars": "50.01", "Date_of_Payment": "09/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "292915702", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "50.00", "Date_of_Payment": "10/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168845892", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "48.00", "Date_of_Payment": "10/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339304962", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "47.51", "Date_of_Payment": "01/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168526046", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "47.24", "Date_of_Payment": "08/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339304944", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "43.63", "Date_of_Payment": "09/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649502", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "43.25", "Date_of_Payment": "12/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189873518", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "42.51", "Date_of_Payment": "07/18/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332513661", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "YERVOY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "40.86", "Date_of_Payment": "05/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328505276", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "Pomalyst", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "38.23", "Date_of_Payment": "04/28/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304910", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "37.50", "Date_of_Payment": "11/07/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111784810", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "37.30", "Date_of_Payment": "07/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339304934", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Cardinal Health 108, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "OH", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010445", "Total_Amount_of_Payment_USDollars": "36.76", "Date_of_Payment": "06/26/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "145688370", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "36.19", "Date_of_Payment": "08/12/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304942", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "35.65", "Date_of_Payment": "03/19/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "339304878", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "35.00", "Date_of_Payment": "10/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168421754", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "35.00", "Date_of_Payment": "10/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168541128", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "35.00", "Date_of_Payment": "03/10/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "263311402", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "SANDOSTATIN LAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "31.80", "Date_of_Payment": "08/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328426276", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "25.89", "Date_of_Payment": "07/18/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332513629", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "YERVOY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "25.89", "Date_of_Payment": "07/18/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332513729", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "YERVOY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "25.00", "Date_of_Payment": "04/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339304914", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "23.97", "Date_of_Payment": "08/13/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "21809145", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "23.37", "Date_of_Payment": "09/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260109726", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FASLODEX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "23.00", "Date_of_Payment": "06/09/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "328257462", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "22.48", "Date_of_Payment": "09/11/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104550572", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "21.88", "Date_of_Payment": "05/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198459960", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "20.89", "Date_of_Payment": "12/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "290464972", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "GILOTRIF", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "20.64", "Date_of_Payment": "03/11/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "187798710", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "YERVOY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Purdue Pharma L.P.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005432", "Total_Amount_of_Payment_USDollars": "19.77", "Date_of_Payment": "02/03/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "251029094", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "OXYCONTIN", "Name_of_Associated_Covered_Drug_or_Biological2": "HYSINGLA ER", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "19.74", "Date_of_Payment": "06/17/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "187927926", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "YERVOY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "19.47", "Date_of_Payment": "11/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189848150", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "19.43", "Date_of_Payment": "11/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317967650", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Rituxan", "Name_of_Associated_Covered_Drug_or_Biological2": "GAZYVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "19.07", "Date_of_Payment": "02/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168915210", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "Tarceva", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "19.00", "Date_of_Payment": "07/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "208154374", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Avastin", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "19.00", "Date_of_Payment": "04/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "208382530", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Avastin", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "18.28", "Date_of_Payment": "07/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311410", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARYDAK", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "18.27", "Date_of_Payment": "04/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318196066", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Perjeta", "Name_of_Associated_Covered_Drug_or_Biological2": "Kadcyla", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "17.92", "Date_of_Payment": "02/24/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311430", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TASIGNA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "17.86", "Date_of_Payment": "08/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649538", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZYKADIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "17.80", "Date_of_Payment": "07/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649494", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "17.69", "Date_of_Payment": "05/05/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331671571", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPRYCEL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "17.33", "Date_of_Payment": "10/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "319456183", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELITEK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "17.28", "Date_of_Payment": "06/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295302264", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "17.27", "Date_of_Payment": "11/05/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24099929", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "17.15", "Date_of_Payment": "09/18/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24099924", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "17.03", "Date_of_Payment": "05/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295116439", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "16.65", "Date_of_Payment": "09/01/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331907475", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "YERVOY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "16.60", "Date_of_Payment": "04/01/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331588233", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "OPDIVO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "16.57", "Date_of_Payment": "11/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649550", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "16.55", "Date_of_Payment": "01/08/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "184747288", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Halaven", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "LILLY USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "16.47", "Date_of_Payment": "08/19/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "137827664", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "CYRAMZA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "16.47", "Date_of_Payment": "03/31/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311420", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SANDOSTATIN LAR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "16.40", "Date_of_Payment": "08/12/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649544", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Bayer HealthCare Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005467", "Total_Amount_of_Payment_USDollars": "16.40", "Date_of_Payment": "10/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "219018924", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Stivarga", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "16.36", "Date_of_Payment": "09/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311406", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "16.23", "Date_of_Payment": "10/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649496", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "15.95", "Date_of_Payment": "10/09/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "14243582", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZALTRAP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "15.82", "Date_of_Payment": "01/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "173389152", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "GRANIX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "15.47", "Date_of_Payment": "02/27/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221254000", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "15.27", "Date_of_Payment": "06/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649534", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZYKADIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "15.01", "Date_of_Payment": "09/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339304952", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "15.00", "Date_of_Payment": "10/01/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104545048", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT ARCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "15.00", "Date_of_Payment": "09/15/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104544806", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT ARCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "15.00", "Date_of_Payment": "05/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198459944", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "15.00", "Date_of_Payment": "04/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198459968", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "15.00", "Date_of_Payment": "02/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198460015", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "15.00", "Date_of_Payment": "02/11/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198460038", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "14.99", "Date_of_Payment": "10/08/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221247750", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "14.94", "Date_of_Payment": "08/27/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29800184", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Perjeta", "Name_of_Associated_Covered_Drug_or_Biological2": "Kadcyla", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "14.84", "Date_of_Payment": "08/28/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24099927", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EXJADE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "14.83", "Date_of_Payment": "01/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "319333723", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JEVTANA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "14.81", "Date_of_Payment": "01/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311404", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EXJADE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "14.43", "Date_of_Payment": "04/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311418", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT RCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "14.42", "Date_of_Payment": "06/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649480", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "14.34", "Date_of_Payment": "05/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649492", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "14.33", "Date_of_Payment": "08/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295257434", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cresemba", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "14.26", "Date_of_Payment": "06/11/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196311020", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "GILOTRIF", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "14.24", "Date_of_Payment": "01/29/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649482", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "14.24", "Date_of_Payment": "09/30/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649488", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EXJADE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "14.13", "Date_of_Payment": "11/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "269966224", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZYTIGA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "14.10", "Date_of_Payment": "02/24/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311428", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARYDAK", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "14.08", "Date_of_Payment": "04/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311422", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TASIGNA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "14.06", "Date_of_Payment": "08/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311408", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "14.03", "Date_of_Payment": "10/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297314942", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Neulasta", "Name_of_Associated_Covered_Drug_or_Biological2": "Vectibix", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "14.00", "Date_of_Payment": "10/04/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104544816", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT ARCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Otsuka America Pharmaceutical, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MD", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010723", "Total_Amount_of_Payment_USDollars": "13.98", "Date_of_Payment": "08/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "333460502", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SAMSCA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "13.89", "Date_of_Payment": "03/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "202773364", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Non-Product", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "13.87", "Date_of_Payment": "11/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311382", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "13.86", "Date_of_Payment": "10/29/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152509332", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Halaven", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "13.71", "Date_of_Payment": "01/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196311022", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "GILOTRIF", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "13.69", "Date_of_Payment": "07/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295126620", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "13.68", "Date_of_Payment": "05/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295290958", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "13.65", "Date_of_Payment": "08/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297915454", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "13.62", "Date_of_Payment": "09/04/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111759590", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "TARCEVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "13.59", "Date_of_Payment": "06/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "138087964", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NEUPOGEN", "Name_of_Associated_Covered_Drug_or_Biological2": "Vectibix", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "LILLY USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "13.52", "Date_of_Payment": "12/03/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "4720531", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "13.47", "Date_of_Payment": "12/11/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24099928", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EXJADE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "13.47", "Date_of_Payment": "12/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "274993730", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XARELTO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "13.40", "Date_of_Payment": "03/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649552", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "13.39", "Date_of_Payment": "03/12/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "184747290", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Halaven", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Onyx Pharmaceuticals, Inc., an Amgen subsidiary", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000276", "Total_Amount_of_Payment_USDollars": "13.30", "Date_of_Payment": "12/04/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "102468150", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "13.23", "Date_of_Payment": "02/18/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331529727", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPRYCEL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "13.22", "Date_of_Payment": "01/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "274993724", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XARELTO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "13.22", "Date_of_Payment": "09/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328428086", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Luitpold Pharmaceuticals Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010540", "Total_Amount_of_Payment_USDollars": "13.04", "Date_of_Payment": "10/22/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "29499411", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Injectafer", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "13.04", "Date_of_Payment": "10/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311362", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARYDAK", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "12.96", "Date_of_Payment": "10/07/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24099934", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "12.91", "Date_of_Payment": "09/24/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "14056268", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPRYCEL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "12.88", "Date_of_Payment": "04/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189941122", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "Pomalyst", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "12.87", "Date_of_Payment": "05/20/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331673517", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELIQUIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "12.67", "Date_of_Payment": "11/26/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "8941495", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Nplate", "Name_of_Associated_Covered_Drug_or_Biological2": "Aranesp", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "12.60", "Date_of_Payment": "01/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322921888", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XALKORI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "12.45", "Date_of_Payment": "09/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311358", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TASIGNA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "12.42", "Date_of_Payment": "09/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "293540646", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TREANDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "12.39", "Date_of_Payment": "07/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339304920", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "12.32", "Date_of_Payment": "11/11/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168887286", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "12.22", "Date_of_Payment": "11/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168562445", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "12.19", "Date_of_Payment": "04/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "138087966", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Neulasta", "Name_of_Associated_Covered_Drug_or_Biological2": "Vectibix", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "12.18", "Date_of_Payment": "11/06/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29800048", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Tarceva", "Name_of_Associated_Covered_Drug_or_Biological2": "Zelboraf", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "12.12", "Date_of_Payment": "01/14/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "188504972", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZALTRAP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "12.10", "Date_of_Payment": "08/06/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24099930", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "12.10", "Date_of_Payment": "03/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "138087962", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Aranesp", "Name_of_Associated_Covered_Drug_or_Biological2": "Nplate", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "12.09", "Date_of_Payment": "10/15/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "171840038", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EMEND", "Name_of_Associated_Covered_Drug_or_Biological2": "INTRON A", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "11.99", "Date_of_Payment": "05/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "274993738", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "11.87", "Date_of_Payment": "12/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "274993726", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XARELTO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ipsen Biopharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000123", "Total_Amount_of_Payment_USDollars": "11.86", "Date_of_Payment": "09/16/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "341511342", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Somatuline Depot 120mg-.5ml", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "11.84", "Date_of_Payment": "11/12/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29800186", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Avastin", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "11.81", "Date_of_Payment": "06/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "274993744", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "11.76", "Date_of_Payment": "09/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323283835", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELIQUIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "11.74", "Date_of_Payment": "03/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322615958", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "IBRANCE", "Name_of_Associated_Covered_Drug_or_Biological2": "XALKORI", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "11.72", "Date_of_Payment": "09/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311360", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JADENU", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "11.72", "Date_of_Payment": "05/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297314900", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Aranesp", "Name_of_Associated_Covered_Drug_or_Biological2": "Nplate", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "11.71", "Date_of_Payment": "03/25/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331573191", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPRYCEL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "11.66", "Date_of_Payment": "08/14/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29800187", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Tarceva", "Name_of_Associated_Covered_Drug_or_Biological2": "Zelboraf", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Diagnostics, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005596", "Total_Amount_of_Payment_USDollars": "11.58", "Date_of_Payment": "07/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "155722566", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Sylvant", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "11.50", "Date_of_Payment": "11/13/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "14295925", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZALTRAP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "11.50", "Date_of_Payment": "06/24/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "322764288", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XALKORI", "Name_of_Associated_Covered_Drug_or_Biological2": "IBRANCE", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Pfizer Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000286", "Total_Amount_of_Payment_USDollars": "11.46", "Date_of_Payment": "02/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "323713172", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "INLYTA", "Name_of_Associated_Covered_Drug_or_Biological2": "SUTENT", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "11.41", "Date_of_Payment": "11/24/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "184747292", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Halaven", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "11.29", "Date_of_Payment": "06/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311394", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARYDAK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "11.18", "Date_of_Payment": "08/20/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29800185", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Avastin", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "11.14", "Date_of_Payment": "12/03/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "188170382", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPRYCEL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "11.03", "Date_of_Payment": "06/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311412", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TASIGNA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "10.99", "Date_of_Payment": "02/26/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649530", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "10.88", "Date_of_Payment": "06/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649486", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EXJADE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "10.70", "Date_of_Payment": "12/23/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332257527", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "OPDIVO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "10.66", "Date_of_Payment": "10/07/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24099933", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Bayer HealthCare Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005467", "Total_Amount_of_Payment_USDollars": "10.66", "Date_of_Payment": "09/10/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "31047942", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Stivarga", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Bayer HealthCare Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005467", "Total_Amount_of_Payment_USDollars": "10.64", "Date_of_Payment": "09/10/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "31070227", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Stivarga", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "10.63", "Date_of_Payment": "09/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "138087968", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Vectibix", "Name_of_Associated_Covered_Drug_or_Biological2": "Neulasta", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "10.62", "Date_of_Payment": "11/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649532", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "10.52", "Date_of_Payment": "10/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311364", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "VOTRIENT RCC", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "10.45", "Date_of_Payment": "09/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198459908", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ARZERRA", "Name_of_Associated_Covered_Drug_or_Biological2": "PROMACTA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "10.38", "Date_of_Payment": "06/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297314938", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Neulasta", "Name_of_Associated_Covered_Drug_or_Biological2": "NEUPOGEN", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "10.34", "Date_of_Payment": "04/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339304890", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "EISAI INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "10.33", "Date_of_Payment": "04/21/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "337968728", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "HALAVEN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "10.28", "Date_of_Payment": "10/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "202766020", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Non-Product", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "9.94", "Date_of_Payment": "10/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649540", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZYKADIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Seattle Genetics, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "WA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000279", "Total_Amount_of_Payment_USDollars": "9.80", "Date_of_Payment": "08/07/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "25422789", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SGN35", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "9.78", "Date_of_Payment": "09/15/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331954505", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ERBITUX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Seattle Genetics, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "WA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000279", "Total_Amount_of_Payment_USDollars": "9.76", "Date_of_Payment": "11/19/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "25422791", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SGN35", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "9.73", "Date_of_Payment": "09/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649546", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "9.61", "Date_of_Payment": "02/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328300010", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "Pomalyst", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "9.42", "Date_of_Payment": "02/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "198460032", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "9.11", "Date_of_Payment": "10/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649548", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "8.89", "Date_of_Payment": "02/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328328638", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Onyx Pharmaceuticals, Inc., an Amgen subsidiary", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000276", "Total_Amount_of_Payment_USDollars": "8.80", "Date_of_Payment": "10/03/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "102468254", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "8.74", "Date_of_Payment": "03/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311424", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SANDOSTATIN LAR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Seattle Genetics, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "WA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000279", "Total_Amount_of_Payment_USDollars": "8.73", "Date_of_Payment": "11/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "341825362", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ADCETRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "8.56", "Date_of_Payment": "11/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311368", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "VOTRIENT RCC", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "8.53", "Date_of_Payment": "05/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649542", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "8.53", "Date_of_Payment": "07/01/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221243934", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "8.20", "Date_of_Payment": "06/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311416", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "8.13", "Date_of_Payment": "10/23/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24099923", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "SANDOSTATIN LAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "8.06", "Date_of_Payment": "10/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311366", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "7.95", "Date_of_Payment": "10/29/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189852970", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "7.68", "Date_of_Payment": "02/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649490", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EXJADE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Seattle Genetics, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "WA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000279", "Total_Amount_of_Payment_USDollars": "7.65", "Date_of_Payment": "04/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "341825350", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ADCETRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "7.64", "Date_of_Payment": "12/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311370", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARYDAK", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Seattle Genetics, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "WA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000279", "Total_Amount_of_Payment_USDollars": "7.62", "Date_of_Payment": "07/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "341825354", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ADCETRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "7.50", "Date_of_Payment": "04/30/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649476", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "SANDOSTATIN LAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "7.36", "Date_of_Payment": "05/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311414", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARYDAK", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Alexion Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005462", "Total_Amount_of_Payment_USDollars": "7.33", "Date_of_Payment": "11/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "338125390", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLIRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Seattle Genetics, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "WA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000279", "Total_Amount_of_Payment_USDollars": "7.33", "Date_of_Payment": "02/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "341825346", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ADCETRIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "7.18", "Date_of_Payment": "11/27/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24099932", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Luitpold Pharmaceuticals Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010540", "Total_Amount_of_Payment_USDollars": "7.08", "Date_of_Payment": "05/20/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "172031690", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Injectafer", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "6.80", "Date_of_Payment": "11/05/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "8941496", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Neulasta", "Name_of_Associated_Covered_Drug_or_Biological2": "XGEVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "6.74", "Date_of_Payment": "03/26/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649484", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "6.56", "Date_of_Payment": "08/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "294906470", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "6.49", "Date_of_Payment": "10/23/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24099926", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "6.44", "Date_of_Payment": "07/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328283520", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "5.94", "Date_of_Payment": "11/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317831414", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Perjeta", "Name_of_Associated_Covered_Drug_or_Biological2": "Kadcyla", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "5.88", "Date_of_Payment": "03/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267746908", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "CYRAMZA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "5.80", "Date_of_Payment": "07/17/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332513563", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "YERVOY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "5.44", "Date_of_Payment": "10/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "221235150", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "5.43", "Date_of_Payment": "12/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168852214", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "5.36", "Date_of_Payment": "09/10/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24099931", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NON BRAND", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "4.89", "Date_of_Payment": "01/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328306602", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "4.87", "Date_of_Payment": "07/01/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221243936", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "3.52", "Date_of_Payment": "07/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "221235018", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "3.19", "Date_of_Payment": "03/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267746904", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "CYRAMZA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "3.04", "Date_of_Payment": "07/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "221235014", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "2.68", "Date_of_Payment": "05/20/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331673501", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELIQUIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "1.93", "Date_of_Payment": "02/13/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "138087960", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Aranesp", "Name_of_Associated_Covered_Drug_or_Biological2": "Nplate", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Luitpold Pharmaceuticals Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010540", "Total_Amount_of_Payment_USDollars": "1.88", "Date_of_Payment": "05/20/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "172031684", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Injectafer", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "1.87", "Date_of_Payment": "08/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "294761616", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Lexiscan", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "1.82", "Date_of_Payment": "05/20/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331673509", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELIQUIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "LILLY USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "1.81", "Date_of_Payment": "12/03/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "4723789", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "1.77", "Date_of_Payment": "03/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267746906", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "CYRAMZA", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Luitpold Pharmaceuticals Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010540", "Total_Amount_of_Payment_USDollars": "1.39", "Date_of_Payment": "10/22/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "29499420", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Injectafer", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "1.07", "Date_of_Payment": "03/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295122118", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "1.04", "Date_of_Payment": "08/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649536", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZYKADIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "0.99", "Date_of_Payment": "04/30/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152649478", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "SANDOSTATIN LAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "0.96", "Date_of_Payment": "10/23/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "24099922", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "SANDOSTATIN LAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "0.95", "Date_of_Payment": "09/15/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331954521", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ERBITUX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.83", "Date_of_Payment": "05/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "274993740", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "0.83", "Date_of_Payment": "11/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318203584", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Perjeta", "Name_of_Associated_Covered_Drug_or_Biological2": "Kadcyla", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "0.82", "Date_of_Payment": "03/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263311426", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZYKADIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "0.81", "Date_of_Payment": "07/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339304916", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Luitpold Pharmaceuticals Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010540", "Total_Amount_of_Payment_USDollars": "0.75", "Date_of_Payment": "10/22/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "29499410", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Injectafer", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "0.73", "Date_of_Payment": "03/25/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331573189", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPRYCEL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.66", "Date_of_Payment": "06/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "274993746", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "0.63", "Date_of_Payment": "10/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339304964", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "0.61", "Date_of_Payment": "05/05/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331671559", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SPRYCEL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "0.61", "Date_of_Payment": "04/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339304892", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "0.58", "Date_of_Payment": "10/08/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221247756", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "0.58", "Date_of_Payment": "08/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "294906502", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xtandi", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "0.54", "Date_of_Payment": "09/01/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "331907497", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "YERVOY", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "0.53", "Date_of_Payment": "08/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297915452", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Kyprolis", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.47", "Date_of_Payment": "12/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "274993728", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XARELTO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "189872", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "0.37", "Date_of_Payment": "01/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "274993732", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}]